335 related articles for article (PubMed ID: 29482150)
1. Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets.
Janjua NZ; Islam N; Kuo M; Yu A; Wong S; Butt ZA; Gilbert M; Buxton J; Chapinal N; Samji H; Chong M; Alvarez M; Wong J; Tyndall MW; Krajden M;
Int J Drug Policy; 2018 May; 55():31-39. PubMed ID: 29482150
[TBL] [Abstract][Full Text] [Related]
2. Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada.
Greenwald ZR; Werb D; Feld JJ; Austin PC; Fridman D; Bayoumi AM; Gomes T; Kendall CE; Lapointe-Shaw L; Scheim AI; Bartlett SR; Benchimol EI; Bouck Z; Boucher LM; Greenaway C; Janjua NZ; Leece P; Wong WWL; Sander B; Kwong JC
J Clin Epidemiol; 2024 Jun; 170():111332. PubMed ID: 38522754
[TBL] [Abstract][Full Text] [Related]
3. Validity of ICD-based algorithms to estimate the prevalence of injection drug use among infective endocarditis hospitalizations in the absence of a reference standard.
McGrew KM; Carabin H; Garwe T; Jafarzadeh SR; Williams MB; Zhao YD; Drevets DA
Drug Alcohol Depend; 2020 Apr; 209():107906. PubMed ID: 32145659
[TBL] [Abstract][Full Text] [Related]
4. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada.
Binka M; Butt ZA; Wong S; Chong M; Buxton JA; Chapinal N; Yu A; Alvarez M; Darvishian M; Wong J; McGowan G; Torban M; Gilbert M; Tyndall M; Krajden M; Janjua NZ
World J Gastroenterol; 2018 Mar; 24(11):1216-1227. PubMed ID: 29568202
[TBL] [Abstract][Full Text] [Related]
5. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
[TBL] [Abstract][Full Text] [Related]
6. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ;
Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135
[TBL] [Abstract][Full Text] [Related]
7. Prescription opioid treatment for non-cancer pain and initiation of injection drug use: large retrospective cohort study.
Wilton J; Abdia Y; Chong M; Karim ME; Wong S; MacInnes A; Balshaw R; Zhao B; Gomes T; Yu A; Alvarez M; Dart RC; Krajden M; Buxton JA; Janjua NZ; Purssell R
BMJ; 2021 Nov; 375():e066965. PubMed ID: 34794949
[TBL] [Abstract][Full Text] [Related]
8. Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants.
Janjua NZ; Kuo M; Chong M; Yu A; Alvarez M; Cook D; Armour R; Aiken C; Li K; Mussavi Rizi SA; Woods R; Godfrey D; Wong J; Gilbert M; Tyndall MW; Krajden M
PLoS One; 2016; 11(3):e0150176. PubMed ID: 26954020
[TBL] [Abstract][Full Text] [Related]
9. A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia.
Butt ZA; Shrestha N; Wong S; Kuo M; Gesink D; Gilbert M; Wong J; Yu A; Alvarez M; Samji H; Buxton JA; Johnston JC; Cook VJ; Roth D; Consolacion T; Murti M; Hottes TS; Ogilvie G; Balshaw R; Tyndall MW; Krajden M; Janjua NZ;
PLoS One; 2017; 12(8):e0183609. PubMed ID: 28829824
[TBL] [Abstract][Full Text] [Related]
10. Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis.
Hines LA; Trickey A; Leung J; Larney S; Peacock A; Degenhardt L; Colledge S; Hickman M; Grebely J; Cunningham EB; Stone J; Dumchev K; Griffiths P; Vickerman P; Mattick RP; Lynskey M
Lancet Glob Health; 2020 Jan; 8(1):e76-e91. PubMed ID: 31839143
[TBL] [Abstract][Full Text] [Related]
11. The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia.
Butler K; Day C; Dietze P; Bruno R; Alati R; Burns L
J Subst Abuse Treat; 2015 Nov; 58():90-4. PubMed ID: 26117080
[TBL] [Abstract][Full Text] [Related]
12. Validation of an Algorithm to Identify Infective Endocarditis in People Who Inject Drugs.
Ball LJ; Sherazi A; Laczko D; Gupta K; Koivu S; Weir MA; Mele T; Tirona R; McCormick JK; Silverman M
Med Care; 2018 Oct; 56(10):e70-e75. PubMed ID: 29200131
[TBL] [Abstract][Full Text] [Related]
13. Syndemic profiles of people living with hepatitis C virus using population-level latent class analysis to optimize health services.
Clementi E; Bartlett S; Otterstatter M; Buxton JA; Wong S; Yu A; Butt ZA; Wilton J; Pearce M; Jeong D; Binka M; Adu P; Alvarez M; Samji H; Abdia Y; Wong J; Krajden M; Janjua NZ;
Int J Infect Dis; 2020 Nov; 100():27-33. PubMed ID: 32810594
[TBL] [Abstract][Full Text] [Related]
14.
Mittal ML; Guise A; Rafful C; Gonzalez-Zuñiga P; Davidson P; Vashishtha D; Strathdee SA; Werb D
Subst Use Misuse; 2019; 54(14):2338-2350. PubMed ID: 31389282
[No Abstract] [Full Text] [Related]
15. Predictors of injecting cessation among a cohort of people who inject drugs in Tijuana, Mexico.
Horyniak D; Strathdee SA; West BS; Meacham M; Rangel G; Gaines TL
Drug Alcohol Depend; 2018 Apr; 185():298-304. PubMed ID: 29482055
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 vaccine effectiveness by HIV status and history of injection drug use: a test-negative analysis.
Puyat JH; Wilton J; Fowokan A; Janjua NZ; Wong J; Grennan T; Chambers C; Kroch A; Costiniuk CT; Cooper CL; Lauscher D; Strong M; Burchell AN; Anis A; Samji H;
J Int AIDS Soc; 2023 Oct; 26(10):e26178. PubMed ID: 37885156
[TBL] [Abstract][Full Text] [Related]
17. A multimorbidity model for estimating health outcomes from the syndemic of injection drug use and associated infections in the United States.
Chiosi JJ; Mueller PP; Chhatwal J; Ciaranello AL
BMC Health Serv Res; 2023 Jul; 23(1):760. PubMed ID: 37461007
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy.
Janjua NZ; Darvishian M; Wong S; Yu A; Rossi C; Ramji A; Yoshida EM; Butt ZA; Samji H; Chong M; Chapinal N; Cook D; Alvarez M; Tyndall M; Krajden M;
Hepatol Commun; 2019 Apr; 3(4):478-492. PubMed ID: 30976739
[TBL] [Abstract][Full Text] [Related]
19. Missed Opportunities for Human Immunodeficiency Virus (HIV) Testing During Injection Drug Use-Related Healthcare Encounters Among a Cohort of Persons Who Inject Drugs With HIV Diagnosed During an Outbreak-Cincinnati/Northern Kentucky, 2017-2018.
Furukawa NW; Blau EF; Reau Z; Carlson D; Raney ZD; Johnson TK; Deputy NP; Sami S; McClung RP; Neblett-Fanfair R; de Fijter S; Ingram T; Thoroughman D; Vogel S; Lyss SB
Clin Infect Dis; 2021 Jun; 72(11):1961-1967. PubMed ID: 32748940
[TBL] [Abstract][Full Text] [Related]
20. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
